◆ Listed stock · SAN.PA

Sanofi

French pharmaceutical company.

Open the chart

◆ Live market

…

24h

—

Ticker
SAN.PA
Category
Stocks & ETFs
Type
Listed stock
Group
Healthcare & Biotech
Trading hours
Market sessions

What is Sanofi?

Laboratoire pharmaceutique français. A share represents part ownership of a listed company. Its price reflects investors' expectations of future earnings.

How Sanofi works and what gives it value

The stock reacts to quarterly results, management guidance, sector news and the rate backdrop. Earnings releases often cause big opening gaps.

What moves the price of Sanofi

  • ◆Earnings and guidance
  • ◆Interest rates
  • ◆Sector news
  • ◆Buybacks and dividends

Key metrics to watch

  • ◆Revenue growth
  • ◆Margins
  • ◆P/E ratio
  • ◆Earnings dates

Risks specific to Sanofi

  • ◆Earnings disappointments
  • ◆High valuation
  • ◆Regulatory risk

How to analyse Sanofi on GraphTrade

Daily and weekly; market open only during sessions. Open the SAN.PA chart, add the indicators below, compare Sanofi with similar assets in Performance and ask the AI Compass to explain the latest move with news and macro context.

Themes

Included in: Santé & biotechnologies.

◆ Indicators suited to Sanofi

◆ FAQ

What is Sanofi (SAN.PA)?

French pharmaceutical company.

Why is Sanofi going up or down today?

The main drivers are: earnings and guidance, interest rates, sector news, buybacks and dividends. The AI Compass cross-references these with today's news.

Which indicators work best on Sanofi?

Daily and weekly; market open only during sessions.

What are the risks of Sanofi?

Earnings disappointments ; High valuation ; Regulatory risk.

How do I follow Sanofi in real time?

Open the free GraphTrade chart for SAN.PA: price updates live, with all indicators.

How do I add Sanofi to my portfolio?

Click « Add to portfolio » on this page: the asset joins your active portfolio.

Is this investment advice?

No. GraphTrade provides information and analysis tools only.

◆ Assets similar to Sanofi

Information only, not investment advice.